These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29461800)

  • 21. Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice.
    Sousa SA; Ulrich M; Bragonzi A; Burke M; Worlitzsch D; Leitão JH; Meisner C; Eberl L; Sá-Correia I; Döring G
    Cell Microbiol; 2007 Dec; 9(12):2817-25. PubMed ID: 17627623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
    Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM
    BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The OmpR Regulator of Burkholderia multivorans Controls Mucoid-to-Nonmucoid Transition and Other Cell Envelope Properties Associated with Persistence in the Cystic Fibrosis Lung.
    Silva IN; Pessoa FD; Ramires MJ; Santos MR; Becker JD; Cooper VS; Moreira LM
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29914989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
    Bernier SP; Son S; Surette MG
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter.
    Gautam V; Singhal L; Ray P
    Indian J Med Microbiol; 2011; 29(1):4-12. PubMed ID: 21304187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
    Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution towards Virulence in a
    Schaefers MM; Wang BX; Boisvert NM; Martini SJ; Bonney SL; Marshall CW; Laub MT; Cooper VS; Priebe GP
    mBio; 2021 Aug; 12(4):e0182321. PubMed ID: 34372701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multifarious, multireplicon Burkholderia cepacia complex.
    Mahenthiralingam E; Urban TA; Goldberg JB
    Nat Rev Microbiol; 2005 Feb; 3(2):144-56. PubMed ID: 15643431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.
    Gilchrist FJ; Webb AK; Bright-Thomas RJ; Jones AM
    J Cyst Fibros; 2012 Sep; 11(5):458-60. PubMed ID: 22551926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.
    Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP
    BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Oxygen-Sensing Two-Component System in the Burkholderia cepacia Complex Regulates Biofilm, Intracellular Invasion, and Pathogenicity.
    Schaefers MM; Liao TL; Boisvert NM; Roux D; Yoder-Himes D; Priebe GP
    PLoS Pathog; 2017 Jan; 13(1):e1006116. PubMed ID: 28046077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer.
    Mitev GM; Mellbye BL; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3700-4. PubMed ID: 19581453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.